Company · CIK 2130606

# Obsidian Therapeutics, Inc.

| CIK | [2130606](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002130606) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Business address | MA |
| Listed | OBX (Nasdaq) |
| First annual or quarterly report | 2026-08-14 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-298642 | Registered company Effective | 2026-08-28 | 2026-09-09 | 2 |

## Filings

 3

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-09-09 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2130606/999999999526002925/9999999995-26-002925-index.htm) Declared effective | 333-298642 | 9999999995-26-002925 |
| 2026-08-28 | [S-1](https://www.sec.gov/Archives/edgar/data/2130606/000119312526374729/0001193125-26-374729-index.htm) Registration filed | 333-298642 | 0001193125-26-374729 |
| 2026-07-02 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2130606/999999999526002188/9999999995-26-002188-index.htm) Declared effective | 333-295249 | 9999999995-26-002188 |

[All filings of this company](https://equitycapital.markets/filings?cik=2130606) · [CSV](https://equitycapital.markets/filings.csv?cik=2130606)

---
Source page: https://equitycapital.markets/company/2130606 · Data: U.S. SEC EDGAR · CC BY 4.0